Remove Obesity Remove Peripheral Arterial Disease Remove Sudden Cardiac Death
article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

11 Despite the link between inflammation and cardiovascular disease has been proven by extensive research, most physicians have focused on treating high-risk patients with lipid lowering therapies including statin therapy.1,12,13 For most patients we can use high sensitivity C-reactive protein (hsCRP) to determine residual inflammatory risk.21-23

article thumbnail

ACC/AHA Release Updated 2023 Guidelines for Atrial Fibrillation

Cardiometabolic Health Congress

This is due to several factors, including the aging of the population, a rise in obesity, increased detection, and increased survival with AF along with other forms of CVD. Background Atrial fibrillation, the most sustained common arrhythmia, is increasing in incidence and prevalence in the United States and globally.